PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kalikaki A et al. – The data indicate that EGFR mutation status could be predictive for response to cytotoxic front–line chemotherapy in patients with NSCLC. Additional prospective studies are needed in order to validate this observation and to define whether these patients should be preferentially treated with front–line TKIs or chemotherapy.

Today in Hematology/Oncology...keeping you current

Intraspinal techniques for pain management in cancer patients: a systematic review
Supportive Care in Cancer, 12/04/09

Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome
JACC - Journal of the American College of Cardiology, 12/04/09

Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address